Rapid Therapeutic Science Laboratories, Inc.

Rapid Therapeutic Science Laboratories, Inc.verified

RTSL

Price:

$0.002

Market Cap:

$17.66K

Rapid Therapeutic Science Laboratories, Inc. operates as a biotech company. The company engages in the aerosol delivery of non-psychoactive cannabinoids to the blood stream for treatment of chronic pain, post-traumatic stress disorder, insomnia, surgery recovery, and other ailments. It offers pressurized meter dose inhaler, a device that delivers a measured amount of aerosolized inhalant in a mist to the lungs; sublingual oral spray devices; and water-soluble cannabidiol and cannabigerol isolates under the nhaler brand. The company was formerly known as Holly Brothers Pictures, Inc. and changed its name to Rapid Therapeutic Science Laboratories, Inc. in January 2020. Rapid Therapeutic Scienc...[Read more]

Industry

Medical - Devices

IPO Date

2017-06-14

Stock Exchange

OTC

Ticker

RTSL

The PE Ratio as of December 2025 (TTM) for Rapid Therapeutic Science Laboratories, Inc. (RTSL) is 0.20

According to Rapid Therapeutic Science Laboratories, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 0.20. This represents a change of -98.28% compared to the average of 11.64 of the last 4 quarters.

Rapid Therapeutic Science Laboratories, Inc. (RTSL) Historical PE Ratio (quarterly & annually)

How has RTSL PE Ratio performed in the past?

The mean historical PE Ratio of Rapid Therapeutic Science Laboratories, Inc. over the last ten years is -5.21. The current 0.20 PE Ratio has changed -484.00% with respect to the historical average. Over the past ten years (40 quarters), RTSL's PE Ratio was at its highest in in the December 2022 quarter at 47.21. The PE Ratio was at its lowest in in the March 2015 quarter at -677.50.

Quarterly (TTM)
Annual

Average

-5.21

Median

-3.43

Minimum

-13.53

Maximum

0

Rapid Therapeutic Science Laboratories, Inc. (RTSL) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Rapid Therapeutic Science Laboratories, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 654.85%

Maximum Annual PE Ratio = 0

Minimum Annual Increase = -Infinity%

Minimum Annual PE Ratio = -13.53

Quarterly (TTM)
Annual
YearPE RatioChange
2022-3.43654.85%
2021-0.45370.23%
2020-0.1092.39%
2018-0.05-99.33%
2017-7.52-44.39%
2016-13.532.35%
2015-13.2254.08%
2014-8.58-Infinity%

Rapid Therapeutic Science Laboratories, Inc. (RTSL) Average PE Ratio

How has RTSL PE Ratio performed in the past?

The current PE Ratio of Rapid Therapeutic Science Laboratories, Inc. (RTSL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-1.33

5-year avg

-2.31

10-year avg

-5.21

Rapid Therapeutic Science Laboratories, Inc. (RTSL) PE Ratio vs. Peers

How is RTSL’s PE Ratio compared to its peers?

Rapid Therapeutic Science Laboratories, Inc.’s PE Ratio is greater than NMC Health plc (0.00), greater than Diagnocure, Inc. (-0.00), greater than NutraLife BioSciences, Inc. (-0.00), less than Cantabio Pharmaceuticals, Inc. (0), greater than MagForce AG (-329.76), less than Humanigen, Inc. (0), greater than QSAM Biosciences, Inc. (-6.67), greater than Hempfusion Wellness Inc. (0), greater than Nanomix Corporation (-0.00), greater than New You, Inc. (-0.00),

Build a custom stock screener for Rapid Therapeutic Science Laboratories, Inc. (RTSL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rapid Therapeutic Science Laboratories, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Rapid Therapeutic Science Laboratories, Inc. (RTSL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Rapid Therapeutic Science Laboratories, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Rapid Therapeutic Science Laboratories, Inc.'s PE Ratio?

How is the PE Ratio calculated for Rapid Therapeutic Science Laboratories, Inc. (RTSL)?

What is the highest PE Ratio for Rapid Therapeutic Science Laboratories, Inc. (RTSL)?

What is the 3-year average PE Ratio for Rapid Therapeutic Science Laboratories, Inc. (RTSL)?

What is the 5-year average PE Ratio for Rapid Therapeutic Science Laboratories, Inc. (RTSL)?

How does the current PE Ratio for Rapid Therapeutic Science Laboratories, Inc. (RTSL) compare to its historical average?